Latest / Morning Medical with Dr. Chow / Smoking Cessation Updates, AI in Healthcare, Cannabis Risks, and New GLP-1 Weight Loss Pill

Transcript

Smoking Cessation Updates, AI in Healthcare, Cannabis Risks, and New GLP-1 Weight Loss Pill · Morning Medical with Dr. Chow

• 0:00
  Welcome to Morning Medical with Dr.
• 0:01
  Chow, where we explore the latest in health and medical news from around the globe.
• 0:06
  I'm your host, Dr.
• 0:07
  Chi-Ming Chow, and today we're diving into some intriguing developments that could impact your
• 0:12
  health and well-being.
• 0:16
  First on today's docket, we're taking a look at a new recommendation from Canadian researchers
• 0:21
  concerning smoking cessation.
• 0:24
  Traditionally, many have turned to vaping as an alternative to smoking, but new guidance
• 0:29
  suggests this might not be the best approach.
• 0:33
  The Canadian Task Force on Preventive Health Care has published recommendations in the
• 0:37
  Canadian Medical Association Journal, urging that vaping should be a last resort for those
• 0:42
  trying to quit smoking.
• 0:45
  The task force is encouraging doctors to engage with their patients who smoke, helping them to
• 0:50
  develop tailored plans to quit.
• 0:52
  These plans could involve primary care advice, individual or group counseling sessions with
• 0:57
  trained cessation counselors, and the use of nicotine replacements like gum or patches.
• 1:03
  Prescription medications are also part of the recommended strategies.
• 1:08
  According to Dr.
• 1:09
  Eddy Lang, a professor at the University of Calgary and a member of the task force, smoking
• 1:15
  remains a leading preventable cause of death and illness in Canada.
• 1:19
  The task force aims to clarify the best options available to help individuals quit smoking
• 1:25
  effectively.
• 1:27
  While some methods like acupuncture, hypnotherapy, and electrostimulation have
• 1:31
  uncertain data regarding their effectiveness, the task force has also expressed concerns
• 1:36
  about the use of e-cigarettes.
• 1:38
  Despite some health agencies, like Johns Hopkins Medicine, acknowledging that vaping is
• 1:43
  less harmful than smoking traditional cigarettes, the presence of chemicals like
• 1:47
  nicotine and heavy metals in e-cigarettes is worrisome.
• 1:51
  These chemicals can include nickel and tin, and the vapors contain carcinogens similar to those
• 1:56
  found in cigarettes.
• 1:59
  Dr.
• 2:00
  Lang highlights the lack of long-term safety data on e-cigarette use, emphasizing that they
• 2:05
  should only be considered when other options have failed or when smokers are not willing to
• 2:10
  try other methods.
• 2:12
  The task force is particularly concerned about normalizing e-cigarette use, given its
• 2:17
  prominence and the availability of flavored options that appeal to younger populations.
• 2:23
  Supporting this concern, a recent analysis from the University of York, in collaboration with
• 2:29
  the London School of Hygiene and Tropical Medicine, found consistent evidence that young
• 2:34
  people who vape are three times more likely to start smoking traditional cigarettes.
• 2:40
  The analysis also linked vaping to an increased risk of respiratory issues and the use of other
• 2:46
  substances like marijuana and alcohol.
• 2:50
  It's clear that while quitting smoking is challenging, the health benefits are
• 2:54
  substantial.
• 2:56
  The task force hopes these new guidelines will provide a clearer path for those looking to
• 3:00
  quit, reinforcing the importance of exploring multiple options and not relying solely on
• 3:05
  vaping as an alternative.
• 3:09
  Now, let's shift gears to a fascinating development in the field of healthcare
• 3:13
  technology—artificial intelligence.
• 3:15
  Over the past few years, artificial intelligence has been making its way into
• 3:19
  various sectors, including healthcare, and its presence is only expected to grow.
• 3:24
  From automating patient documents in electronic medical records to assisting with diagnostics
• 3:30
  and enhancing precision medicine, artificial intelligence is transforming how we approach
• 3:35
  healthcare.
• 3:37
  Artificial intelligence, at its core, refers to a broad range of technologies that enable
• 3:42
  machines to perform tasks that typically require human intelligence.
• 3:48
  For example, traditional artificial intelligence systems can manage large volumes
• 3:53
  of patient records, helping to avoid duplication of information and handle
• 3:57
  time-consuming administrative tasks.
• 4:00
  This has been incredibly useful in streamlining healthcare operations and allowing healthcare
• 4:05
  providers to focus more on patient care.
• 4:09
  One of the exciting areas within artificial intelligence is generative artificial
• 4:14
  intelligence, which is a specialized tool focused on creating new content, such as text
• 4:19
  and images.
• 4:21
  In healthcare, generative artificial intelligence has shown great potential,
• 4:25
  particularly when it comes to patient relations and outcomes.
• 4:29
  Imagine a generative artificial intelligence-based patient care solution that
• 4:34
  can analyze a patient's medical history, symptoms, test results, and personal
• 4:39
  preferences to generate a customized treatment plan.
• 4:42
  This could significantly enhance the way healthcare is delivered, making it more
• 4:46
  personalized and efficient.
• 4:49
  Primary care, with its focus on managing large numbers of patients with complex risks for
• 4:54
  various conditions, could be a fertile ground for artificial intelligence transformation.
• 5:00
  Picture a primary care provider with access to a generative artificial intelligence system
• 5:05
  during a patient examination.
• 5:08
  This system could parse data, suggest follow-up questions, summarize previous exam notes, and
• 5:14
  provide alerts such as abnormal test results.
• 5:18
  It would effectively free up the primary care provider to focus more on the patient,
• 5:23
  potentially improving the quality of care.
• 5:26
  A recent survey conducted by the American Academy of Family Physicians in partnership
• 5:31
  with Rock Health engaged over twelve hundred family physicians and other primary care
• 5:37
  providers to gauge their perceptions of digital health and artificial intelligence tools.
• 5:43
  The survey, which ran from September through November 2024, revealed that most primary care
• 5:49
  providers already use digital health tools in their daily work and are open to considering
• 5:54
  artificial intelligence.
• 5:57
  Traditional artificial intelligence is used on at least a weekly basis by the majority of
• 6:02
  respondents, with ninety-two percent using electronic health records and eighty-three
• 6:07
  percent utilizing clinical decision support tools.
• 6:11
  Interestingly, more than thirty percent of these providers are actively seeking additional
• 6:16
  new technologies.
• 6:17
  Moreover, sixty-two percent of primary care providers report using generative artificial
• 6:22
  intelligence tools in their personal lives, with eighty percent of those who do not
• 6:27
  expressing interest in doing so.
• 6:30
  Despite this openness to technology, respondents indicated that they have little to
• 6:34
  no involvement in selecting, purchasing, or developing the artificial intelligence tools
• 6:40
  they use.
• 6:41
  This is largely due to the current employment models and organizational leadership driving
• 6:46
  these decisions.
• 6:48
  However, the transition from paper to electronic medical records has shown that
• 6:53
  long-term success with artificial intelligence in primary care will require buy-in from users
• 6:59
  themselves.
• 7:01
  While many primary care providers anticipate improvements in clinical efficiency and
• 7:06
  personal well-being thanks to artificial intelligence, concerns remain.
• 7:10
  About thirty-nine percent of respondents reported experiencing burnout, and most are
• 7:15
  willing to consider artificial intelligence tools to help alleviate these stresses.
• 7:20
  However, there is skepticism about artificial intelligence's impact on patient satisfaction,
• 7:25
  personalization of care, and clinician-patient relationships.
• 7:30
  Primary care providers are also worried about job security and see a need for more training,
• 7:37
  medico-legal protections, and education on liability and malpractice risks.
• 7:43
  Importantly, sixty-eight percent of respondents believe that ethical guidelines are necessary
• 7:49
  for incorporating artificial intelligence into their practices.
• 7:53
  Although the future of artificial intelligence in healthcare is still unfolding, studies like
• 7:58
  this one provide valuable insights and help chart a course towards its effective
• 8:02
  integration.
• 8:05
  Cannabis gummies have become increasingly popular for their perceived benefits in
• 8:10
  alleviating pain, inflammation, anxiety, and sleep issues.
• 8:15
  However, there's growing concern about these tetrahydrocannabinol-containing gummies
• 8:20
  accidentally falling into the hands of children.
• 8:24
  According to America's Poison Centers, reports of cannabis poisoning among children have
• 8:29
  alarmingly increased from 930 cases in 2009 to over 22,000 cases in 2024.
• 8:38
  Last year alone, more than seventy-five percent of all reported cannabis poisonings involved
• 8:43
  minors.
• 8:45
  Melissa Johnson, a licensed clinical social worker and senior clinical director at Victory
• 8:50
  Starts Now in Los Angeles, points out that the advertising strategies for gummy cannabis often
• 8:56
  resemble those used for candy marketed to children.
• 9:00
  This resemblance has contributed to the significant uptick in cannabis poisonings among
• 9:05
  young people.
• 9:07
  Dr.
• 9:08
  Darria Long, an emergency physician from Atlanta, Georgia, has observed numerous
• 9:13
  instances of children requiring medical attention due to cannabis gummy consumption.
• 9:18
  The danger lies in the fact that children tend not to stop at just one gummy; they may consume
• 9:23
  an entire bag, equating to approximately ten adult servings in a child's body.
• 9:29
  This can lead to severe medical issues.
• 9:32
  The symptoms of cannabis gummy poisoning in children can be severe, including lethargy,
• 9:38
  breathing difficulties, seizures, and in extreme cases, cardiac arrest.
• 9:44
  Dr.
• 9:46
  Long notes that in severe situations, children may require intubation, respiratory support, or
• 9:53
  even electrical pacing of the heart.
• 9:55
  Immediate medical intervention is crucial in these scenarios.
• 10:00
  Dr.
• 10:00
  Margret Chang, a pediatrician at UMass Memorial Health’s Tri-River Family Health Center,
• 10:06
  emphasizes that while severe effects are unlikely after a single exposure with proper
• 10:11
  medical care, the risk increases if the gummies contain illicit substances like fentanyl or
• 10:17
  cocaine.
• 10:18
  These cases can be far more deadly, highlighting the importance of sourcing
• 10:23
  cannabis products from licensed dispensaries.
• 10:27
  To prevent accidental ingestion, experts advise against keeping tetrahydrocannabinol products
• 10:32
  in the home, especially in forms appealing to children, such as gummies or candies.
• 10:38
  If these products are present, they should be stored securely in child-proof containers and
• 10:43
  kept out of reach and sight of children.
• 10:46
  Riana Durrett, director of the Cannabis Policy Institute at the University of Nevada, Las
• 10:52
  Vegas, argues that while the stories of cannabis gummy poisonings are concerning, they
• 10:57
  may not tell the entire story.
• 10:59
  She suggests that youth cannabis use is declining in states where legalization has
• 11:04
  occurred, and understanding the source of these products is essential to addressing the problem
• 11:08
  effectively.
• 11:11
  Now, let's delve into an exciting development in the realm of weight management and diabetes
• 11:17
  treatment.
• 11:19
  Drugmaker Eli Lilly is making strides with a new GLP-1 pill, orforglipron, which could soon
• 11:27
  receive regulatory approval.
• 11:30
  This oral medication is designed to aid in weight loss and manage type 2 diabetes,
• 11:35
  potentially offering a more convenient alternative to injectable forms of GLP-1
• 11:40
  receptor agonists.
• 11:42
  GLP-1 drugs have gained popularity for their effectiveness in weight loss and diabetes
• 11:48
  management.
• 11:49
  However, injectable forms come with certain drawbacks, such as the need for refrigeration
• 11:54
  and the discomfort some individuals feel towards needles.
• 11:58
  In contrast, the pill form could alleviate these issues, providing a more accessible
• 12:03
  option for many.
• 12:05
  The late-stage trial results announced by Eli Lilly reveal that participants taking the
• 12:10
  highest dose of orforglipron lost an average of 22.9 pounds, which is about ten point five
• 12:16
  percent of their body weight, over seventy-two weeks.
• 12:19
  Additionally, the medication significantly lowered A1C levels, which measure average blood
• 12:26
  glucose over three months, by one point eight percent.
• 12:30
  This indicates that the pill is not only effective for weight loss but also beneficial
• 12:35
  for blood sugar control.
• 12:37
  GLP-1 drugs function by stimulating the pancreas to release insulin while suppressing
• 12:44
  another hormone to reduce hunger, helping individuals feel fuller for longer periods.
• 12:51
  This dual action is particularly valuable for those with type 2 diabetes, where insulin
• 12:56
  production is impaired or the body's cells are resistant to insulin's effects.
• 13:01
  The introduction of orforglipron could mark a significant advancement for those struggling
• 13:06
  with obesity and type 2 diabetes.
• 13:09
  Eli Lilly's announcement of having the "full clinical data package" required for regulatory
• 13:14
  submissions signals that this pill may soon be available globally.
• 13:19
  The company's chief scientific officer, Dr.
• 13:22
  Dan Skovronsky, has emphasized their readiness to meet demand by starting mass production of
• 13:27
  the pills after promising trial results.
• 13:31
  While the pill's side effects are reportedly mild to moderate, similar to those associated
• 13:36
  with injectable GLP-1 drugs, the convenience of an oral form could make it an appealing option
• 13:42
  for long-term management.
• 13:43
  Additionally, Eli Lilly is exploring the pill's potential to address other health conditions
• 13:49
  like high blood pressure and sleep apnea, which have shown improvement with injectable GLP-1s.
• 13:57
  As we await the peer-reviewed publication of these trial results, the anticipation for
• 14:03
  orforglipron's approval and availability grows.
• 14:07
  It represents a promising new tool in the toolbox for managing chronic conditions like
• 14:13
  obesity and diabetes, potentially transforming the landscape of treatment options.
• 14:19
  That wraps up today's episode of Morning Medical with Dr.
• 14:22
  Chow.
• 14:23
  Thank you for joining me as we explored these impactful health developments.
• 14:27
  Until next time, stay informed and take care of your health.